دورية أكاديمية
Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.A9BA04F0 877 3 Academic Journal academicJournal 877.047973632813 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.A9BA04F0&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1016/j.intimp.2022.108781# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Ben+Jemaa%2C+Awatef%22">Ben Jemaa, Awatef</searchLink><br /><searchLink fieldCode="AR" term="%22Salhi%2C+Noura%22">Salhi, Noura</searchLink><br /><searchLink fieldCode="AR" term="%22Ben+Othmen%2C+Meriam%22">Ben Othmen, Meriam</searchLink><br /><searchLink fieldCode="AR" term="%22Ben+Ali%2C+Hana%22">Ben Ali, Hana</searchLink><br /><searchLink fieldCode="AR" term="%22Guissouma%2C+Jihene%22">Guissouma, Jihene</searchLink><br /><searchLink fieldCode="AR" term="%22Ghadhoune%2C+Hatem%22">Ghadhoune, Hatem</searchLink><br /><searchLink fieldCode="AR" term="%22Oueslati%2C+Ridha%22">Oueslati, Ridha</searchLink><br /><searchLink fieldCode="AR" term="%22Dhaouadi%2C+Hamdi%22">Dhaouadi, Hamdi</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => International Immunopharmacology ; volume 109, page 108781 ; ISSN 1567-5769 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Elsevier BV ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => ScienceDirect (Elsevier - Open Access Articles via Crossref) ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Pharmacology%22">Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology%22">Immunology</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology+and+Allergy%22">Immunology and Allergy</searchLink> ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/j.intimp.2022.108781 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1016/j.intimp.2022.108781<br />https://api.elsevier.com/content/article/PII:S156757692200265X?httpAccept=text/xml<br />https://api.elsevier.com/content/article/PII:S156757692200265X?httpAccept=text/plain ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://www.elsevier.com/tdm/userlicense/1.0/ ; https://doi.org/10.15223/policy-017 ; https://doi.org/10.15223/policy-037 ; https://doi.org/10.15223/policy-012 ; https://doi.org/10.15223/policy-029 ; https://doi.org/10.15223/policy-004 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.A9BA04F0 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.intimp.2022.108781
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Pharmacology
[Type] => general
)
[1] => Array
(
[SubjectFull] => Immunology
[Type] => general
)
[2] => Array
(
[SubjectFull] => Immunology and Allergy
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ben Jemaa, Awatef
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Salhi, Noura
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ben Othmen, Meriam
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ben Ali, Hana
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Guissouma, Jihene
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ghadhoune, Hatem
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Oueslati, Ridha
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Dhaouadi, Hamdi
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => International Immunopharmacology ; volume 109, page 108781 ; ISSN 1567-5769
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |